Home LiteratureArticle Details
PMID: 7969167 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1, and 53BP2.

Molecular and cellular biology ·Vol. 14 ·No. 12 ·1994-12-00 ·Pages 8315-21

Thukral SK, Blain GC, Chang KK, Fields S

Abstract

We identified a minimal domain of human p53 required for the transactivation of a p53 response element in Saccharomyces cerevisiae. This domain contains the central region of p53 sufficient for specific DNA binding, which colocalizes with the region responsible for binding simian virus 40 large T antigen, 53BP1, and 53BP2. Thirty amino acid positions, including natural mutational hot spots (R175, R213, R248, R249, and R273), in the minimal DNA-binding domain were mutated by alanine substitution. Alanine substitutions at positions R213, R248, R249, D281, R282, R283, E286, and N288 affected transactivation but allowed binding to at least one of the three interacting proteins; these amino acids may be involved in amino acid-base pair contacts. Surprisingly, alanine substitution at the mutational hot spot R175 did not affect DNA binding, transactivation, or T-antigen binding, although it nearly eliminated binding to 53BP1 and 53BP2. Mutation of H168 significantly affected only T-antigen binding, and mutation of E285 affected only 53BP1 binding. Thus, we implicate specific residues of p53 in different DNA and protein interactions.

MeSH Terms
Amino Acid Sequence Antigens, Polyomavirus Transforming/chemistry,metabolism Apoptosis Regulatory Proteins Binding Sites Carrier Proteins/metabolism DNA-Binding Proteins/chemistry,metabolism Humans In Vitro Techniques Intracellular Signaling Peptides and Proteins Molecular Sequence Data Mutagenesis, Site-Directed Phosphoproteins Protein Binding Structure-Activity Relationship Transcriptional Activation Tumor Suppressor Protein p53/chemistry,metabolism Tumor Suppressor p53-Binding Protein 1
Chemicals
Antigens, Polyomavirus Transforming Apoptosis Regulatory Proteins Carrier Proteins DNA-Binding Proteins Intracellular Signaling Peptides and Proteins Phosphoproteins TP53BP1 protein, human TP53BP2 protein, human Tumor Suppressor Protein p53 Tumor Suppressor p53-Binding Protein 1
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Thukral S K
Department of Developmental Biology, AMGEN, Thousand Oaks, California 91320.
Blain G C
Chang K K
Fields S
References (42)
42 references, click to expand
  1. T antigen is bound to a host protein in SV40-transformed cells.
    Nature. 1979 Mar 15;278(5701):261-3 PMID: 218111
  2. p53 domains: identification and characterization of two autonomous DNA-binding regions.
    Genes Dev. 1993 Dec;7(12B):2575-86 PMID: 8276240
  3. Yeast promoters and lacZ fusions designed to study expression of cloned genes in yeast.
    Methods Enzymol. 1983;101:181-91 PMID: 6310321
  4. Rapid and efficient site-specific mutagenesis without phenotypic selection.
    Proc Natl Acad Sci U S A. 1985 Jan;82(2):488-92 PMID: 3881765
  5. A new class of yeast transcriptional activators.
    Cell. 1987 Oct 9;51(1):113-9 PMID: 3115591
  6. Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template.
    Methods Enzymol. 1987;154:329-50 PMID: 3323811
  7. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.
    J Virol. 1989 Feb;63(2):739-46 PMID: 2642977
  8. The p53 proto-oncogene can act as a suppressor of transformation.
    Cell. 1989 Jun 30;57(7):1083-93 PMID: 2525423
  9. A novel genetic system to detect protein-protein interactions.
    Nature. 1989 Jul 20;340(6230):245-6 PMID: 2547163
  10. Mutations in the p53 gene occur in diverse human tumour types.
    Nature. 1989 Dec 7;342(6250):705-8 PMID: 2531845
  11. Presence of a potent transcription activating sequence in the p53 protein.
    Science. 1990 Aug 31;249(4972):1046-9 PMID: 2144363
  12. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis.
    Mol Cell Biol. 1990 Dec;10(12):6565-77 PMID: 2247074
  13. Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.
    Mol Cell Biol. 1991 Jan;11(1):12-9 PMID: 1986215
  14. Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication.
    Cell. 1991 Jun 14;65(6):1083-91 PMID: 1646078
  15. The p53 tumour suppressor gene.
    Nature. 1991 Jun 6;351(6326):453-6 PMID: 2046748
  16. The MCK enhancer contains a p53 responsive element.
    Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4570-1 PMID: 1647009
  17. p53 mutations in human cancers.
    Science. 1991 Jul 5;253(5015):49-53 PMID: 1905840
  18. Analysis of p53 mutants for transcriptional activity.
    Mol Cell Biol. 1991 Dec;11(12):6067-74 PMID: 1944276
  19. Nuclear localization is essential for the activity of p53 protein.
    Oncogene. 1991 Nov;6(11):2055-65 PMID: 1719467
  20. Identification of amino acid-base pair contacts by genetic methods.
    Methods Enzymol. 1991;208:620-40 PMID: 1779850
  21. p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer.
    EMBO J. 1992 Apr;11(4):1383-90 PMID: 1314165
  22. Mammalian p53 can function as a transcription factor in yeast.
    Nucleic Acids Res. 1992 Apr 11;20(7):1539-45 PMID: 1579447
  23. Mutations in the zinc fingers of ADR1 that change the specificity of DNA binding and transactivation.
    Mol Cell Biol. 1992 Jun;12(6):2784-92 PMID: 1588970
  24. A transcriptionally active DNA-binding site for human p53 protein complexes.
    Mol Cell Biol. 1992 Jun;12(6):2866-71 PMID: 1588974
  25. Oncogenic forms of p53 inhibit p53-regulated gene expression.
    Science. 1992 May 8;256(5058):827-30 PMID: 1589764
  26. Cancer. p53, guardian of the genome.
    Nature. 1992 Jul 2;358(6381):15-6 PMID: 1614522
  27. Wild-type p53 activates transcription in vitro.
    Nature. 1992 Jul 2;358(6381):83-6 PMID: 1614538
  28. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.
    Genes Dev. 1992 Jul;6(7):1143-52 PMID: 1628822
  29. A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization.
    Oncogene. 1992 Aug;7(8):1513-23 PMID: 1321401
  30. p53 function and dysfunction.
    Cell. 1992 Aug 21;70(4):523-6 PMID: 1505019
  31. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.
    Genes Dev. 1992 Oct;6(10):1886-98 PMID: 1398068
  32. The p53 tumor suppressor protein: meeting review.
    Genes Dev. 1993 Apr;7(4):529-34 PMID: 8096197
  33. Definition of a consensus binding site for p53.
    Nat Genet. 1992 Apr;1(1):45-9 PMID: 1301998
  34. Analysis of a protein-binding domain of p53.
    Mol Cell Biol. 1993 Jun;13(6):3811-20 PMID: 8388547
  35. Use of the two-hybrid system to identify the domain of p53 involved in oligomerization.
    Oncogene. 1993 Jun;8(6):1693-6 PMID: 8502489
  36. Two cellular proteins that bind to wild-type but not mutant p53.
    Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6098-102 PMID: 8016121
  37. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
    Science. 1994 Jul 15;265(5170):346-55 PMID: 8023157
  38. Gain of function mutations in p53.
    Nat Genet. 1993 May;4(1):42-6 PMID: 8099841
  39. Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants.
    EMBO J. 1993 Dec 15;12(13):5057-64 PMID: 8262048
  40. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.
    Genes Dev. 1993 Dec;7(12B):2556-64 PMID: 8276238
  41. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
    Genes Dev. 1993 Dec;7(12B):2565-74 PMID: 8276239
  42. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.
    Cell. 1979 May;17(1):43-52 PMID: 222475
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1994-12-00
Pages
8315-21
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC359370
Subset
IM
Grants
NCI NIH HHS · 5PO1 CA28146 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]